Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [360]

Highlights of Cancer Prevention Europe

Dr Chris Wild - International Agency for Research on Cancer (IARC), Lyon, France

Highlights of Cancer Prevention Europe ( Dr Chris Wild - International Agency for Research on Cancer (IARC), Lyon, France )

Cancer Core Europe: what has been achieved one year on?

Prof Alexander Eggermont and Prof Julio Celis

Cancer Core Europe: what has been achieved one year on? ( Prof Alexander Eggermont and Prof Julio Celis )

Cancer Prevention Europe

Dr Chris Wild - International Agency for Research on Cancer (IARC), Lyon, France

Cancer Prevention Europe ( Dr Chris Wild - International Agency for Research on Cancer (IARC), Lyon, France )

Cancer Core Europe: one year on (full version)

Prof Alexander Eggermont - Gustave Roussy, Villejuf, France

Cancer Core Europe: one year on (full version) ( Prof Alexander Eggermont - Gustave Roussy, Villejuf, France )

Advancing radiation therapy in pancreatic and liver cancer

Dr Theodore Lawrence - University of Michigan Health System, Ann Arbor, USA

Advancing radiation therapy in pancreatic and liver cancer ( Dr Theodore Lawrence - University of Michigan Health System, Ann Arbor, USA )

Four molecular subtypes identified in pancreatic cancer

Dr David Chang - University of Glasgow, Glasgow, UK

Four molecular subtypes identified in pancreatic cancer ( Dr David Chang - University of Glasgow, Glasgow, UK )

Individualised stereotactic body radiotherapy of liver metastases

Dr Theodore Hong - Massachusetts General Hospital, Boston, USA

Individualised stereotactic body radiotherapy of liver metastases ( Dr Theodore Hong - Massachusetts General Hospital, Boston, USA )

Investigating genetic vulnerabilities to radiation therapy

Dr Mohamed Abazeed – Cleveland Clinic, Cleveland, USA

Investigating genetic vulnerabilities to radiation therapy ( Dr Mohamed Abazeed – Cleveland Clinic, Cleveland, USA )

ecancermedicalscience editor's choice for September 2015

Prof Gordon McVie - ecancer Managing Editor

ecancermedicalscience editor's choice for September 2015 ( Prof Gordon McVie - ecancer Managing Editor )

Surgery in synchronous oligometastatic disease

Prof Peter Naredi - University of Gothenburg, Gothenburg, Sweden

Surgery in synchronous oligometastatic disease ( Prof Peter Naredi - University of Gothenburg, Gothenburg, Sweden )

Nivolumab improves overall survival for advanced kidney cancer

Prof Padmanee Sharma - MD Anderson Cancer Center, Houston, USA

Nivolumab improves overall survival for advanced kidney cancer ( Prof Padmanee Sharma - MD Anderson Cancer Center, Houston, USA )

New research into new small molecule IKKα inhibitors

Dr Elaine Willmore – University of Newcastle, Newcastle, UK

New research into new small molecule IKKα inhibitors ( Dr Elaine Willmore – University of Newcastle, Newcastle, UK )

More from ecancer